Residency: University Hospital, SUNY Health Science Center at Syracuse, 1993, Radiation Oncology
Residency: University of Maryland Medical Systems, 1990, Internal Medicine
MD: SUNY Health Science Center at Syracuse, 1989
Clinical Interests
Lung cancer
Prostate cancer including IMRT and brachytherapy
Breast cancer
Lymphoma
Pediatric oncology
Research Interests
Lung and prostate cancer
Clinical investigations through cooperative clinical trials
Chair: CALGB Radiation Oncology Committee
Specialties & Certification
Radiation Oncology
Diseases & Conditions Treated
All Cancers and Hematological Conditions
Esophageal Cancer
Lung Cancer
Prostate Cancer
Urologic Cancers
Treats
Adults and Children
Treatments/Services
Gamma Knife Radiosurgery
Image Guided Radiation Therapy (IGRT)
Intensity Modulated Radiation Therapy (IMRT)
Internal Radiation
Mammosite Brachytherapy
Prostate Brachytherapy
Radiation Therapy
Stereotactic Body Radiation Therapy (SBRT)
Total Skin Irradiation
Current Hospital Privileges
Upstate University Hospital
Crouse Hospital
St. Joseph's Hospital Health Center
VA Medical Center
HealthLinkOnAir Radio Interview
8/12/12 New study for the treatment of prostate cancer
Publications
Link to PubMed (Opens new window. Close the PubMed window to return to this page.)
Research Abstract
Video Assisted Wedge Resection (VAR) and Radiotherapy for High Risk T1 Non-Small Cell Lung Cancer: A CALGB Phase II Study. With H. Shennib, H. Kreisman, L. Kohman, D. Sugarbaker, M. Green, J. Herndon
This national cooperative group study seeks to evaluate the role of local radiotherapy after thoracoscopic wedge resection in non-small cell carcinoma. Participating patients are required to have poor pulmonary function placing them at high risk for complications with a standard open thoracotomy approach. As a higher incidence of local recurrence is recognized to be an important cause of failure of limited resections through thoracotomy, and is likely to become more pronounced with the new technique of VAR, and, since locoregional recurrence constitutes at least 50% of the comorbid terminal events in patients who die from lung cancer following resection, it would appear pertinent to explore the role of radiotherapy as an adjuvant to wedge resection, particularly through VAR, of peripheral T1-NSCLC.